AEE
43
-3
SNA
60
5
AME
59
2
PHM
74
3
DVN
39
3
QCOM
82
2
BLK
61
3
MMM
32
2
PAYX
47
6
ZION
59
4
SYF
97
2
JCI
35
4
FSLR
78
8
TSCO
56
6
WBA
28
4
MNST
65
5
KLAC
65
2
KMX
49
2
GWW
48
4
SWKS
42
5
AEE
43
-3
SNA
60
5
AME
59
2
PHM
74
3
DVN
39
3
QCOM
82
2
BLK
61
3
MMM
32
2
PAYX
47
6
ZION
59
4
SYF
97
2
JCI
35
4
FSLR
78
8
TSCO
56
6
WBA
28
4
MNST
65
5
KLAC
65
2
KMX
49
2
GWW
48
4
SWKS
42
5
Financhill
Back

NLS Pharmaceutics Quote, Financials, Valuation and Earnings

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
34

NLSP
NLS Pharmaceutics

Last Price:
0.13
Seasonality Move:
-39.64%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

NLS Pharmaceutics Price Quote

$0.13
-0.01 (-4.41%)
(Updated: May 4, 2024 at 6:29 AM ET)

NLS Pharmaceutics Key Stats

Sell
34
NLS Pharmaceutics (NLSP) is a Sell
Day range:
$0.13 - $0.14
52-week range:
$0.11 - $1.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
67K
Avg. volume:
332K
1-year change:
-89.7%
Market cap:
$6M
Revenue:
$0
EPS:
$-0.5

How Much Does NLS Pharmaceutics Make?

Data Unavailable

Is NLS Pharmaceutics Growing As A Company?

Data Unavailable

NLS Pharmaceutics Stock Price Performance

  • Did NLS Pharmaceutics Stock Go Up Last Month?
    NLS Pharmaceutics share price went down by -13.75% last month
  • Did NLSP's Share Price Rise Over The Last Year?
    NLSP share price fell by -89.7% over the past 1 year

What Is NLS Pharmaceutics 52-Week High & Low?

NLS Pharmaceutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NLS Pharmaceutics?

  • How Much Debt Does NLS Pharmaceutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does NLS Pharmaceutics Have?
    Cash and short term investments quarterly total is $1.7M
  • What Is NLS Pharmaceutics’s Book Value Per Share?
    Book value per share is -0.12

Is NLS Pharmaceutics Cash Flow Positive?

  • What Is NLSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.5M
  • What Is NLS Pharmaceutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $13.8M
  • What Is NLS Pharmaceutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

NLS Pharmaceutics Return On Invested Capital

Data Unavailable

NLS Pharmaceutics Earnings Date & Stock Price

NLS Pharmaceutics Competitors

  • Who Are NLS Pharmaceutics's Competitors?
    Below is a list of companies who compete with NLS Pharmaceutics or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • MoonLake Immunotherapeutics (MLTX)
    • Molecular Partners AG (MOLN)

NLS Pharmaceutics Dividend Yield

Data Unavailable

NLS Pharmaceutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 4247.83%

Major Shareholders

  • How many NLSP shares are owned by institutional investors?
    198K NLSP shares are owned by institutional investors
  • How many NLSP shares are owned by insiders?
    0 NLSP shares are owned by insiders